Ather launches new Rizta S 3.7kWh variant in India at Rs 1.37 lakh
Since its debut in 2024, the Rizta series has become a key player in Ather's portfolio, quickly earning its place as the company's best-selling scooter. With over 1 lakh units sold within a year, the Rizta now contributes more than 60% to Ather's total sales. The new 3.7kWh variant builds on this momentum, offering customers another solid choice that blends affordability with performance and convenience.
The Rizta has always stood out for its practical design and high build quality, and the new variant stays true to that promise. It retains the generous 34-litre underseat storage—expandable to 56 litres with an optional Frunk—and one of the roomiest seats in its segment, ensuring comfort for both the rider and pillion. The floorboard is thoughtfully designed for daily usability, and Ather's commitment to rigorous engineering standards means this new version is just as reliable and robust as its siblings.
What makes this variant especially appealing is how well it balances cost with features. The Rizta S 3.7kWh comes loaded with Ather's DeepView™ 7-inch display offering Turn-by-Turn Navigation, along with a suite of smart and safety-focused features like AutoHold™, Fall Safe, Emergency Stop Signal, and anti-theft alerts. It also supports voice control via Alexa and is OTA-update ready, so the scooter can get better over time with new software updates.
Charging is also a breeze—owners can use the extensive Ather Grid network, which now includes over 3,900 public charging stations across India. For home use, Ather's plug-and-play charging solution makes overnight top-ups simple and reliable.
Customers will also benefit from Ather's 'Eight70' warranty program, which guarantees 70% battery health for up to 8 years or 80,000 km, whichever comes first. This new variant is available through Ather's retail network and online store, with deliveries set to begin soon.
City-specific pricing is competitive: ₹1,37,047 in Delhi, ₹1,37,258 in Mumbai, ₹1,37,999 in Bangalore, and ₹1,39,312 in Chennai—positioning the Rizta S 3.7kWh as one of the most compelling long-range electric scooters in its segment.
Ahmedabad Plane Crash
Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at BusinessUpturn.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
5 hours ago
- Business Upturn
LGI Homes Unveils $3M Amenity Center at Jennings Farm in Middleburg, FL
MIDDLEBURG, Fla., July 01, 2025 (GLOBE NEWSWIRE) — LGI Homes, Inc. (NASDAQ:LGIH) proudly announces the grand opening of the amenity center at Jennings Farm. With over $3,000,000 invested, this new area enhances the tight-knit feel of this incredible community. Situated along Jennings Farm Dr., the recently completed amenity center offers plenty of opportunities for summertime fun. Homeowners can escape the heat at the incredible community swimming pool or let their kids run around at the playground. The amenity center also features a picnic-ready party lawn, pickleball courts and expansive dog park. Advertisement 'We're excited to open our exceptional new amenity center, complete with a resort-style pool, pickleball courts, a dog park, and so much more,' said Joe Lamoureux, Vice President of Sales for Florida. 'With the peaceful sound of water from the community ponds and Black Creek, the safety of a gated community, and a location right across from A-Rated Middleburg High School, Jennings Farm is the perfect place to call home. At Jennings Farm we're building a community where families can relax, connect, and enjoy life together.' Located right off of Highway 21, Jennings Farm features an impressive collection of six floor plans, all equipped with our exclusive CompleteHome Plus™ package. Enjoy eye-catching front-yard landscaping, a full suite of Whirlpool kitchen appliances, quartz countertops, smart-home technology and more at no added cost to you. Homes are available at Jennings Farm starting in the mid-$300s, with immediate move-in options available. To schedule a tour or for additional information please call (855) 617-4289 ext 293 or visit About LGI Homes Headquartered in The Woodlands, Texas, LGI Homes, Inc. is a pioneer in the homebuilding industry, successfully applying an innovative and systematic approach to the design, construction and sale of homes across 36 markets in 21 states. As one of America's fastest growing companies, LGI Homes has closed over 75,000 homes since its founding in 2003 and has delivered profitable financial results every year. Nationally recognized for its quality construction and exceptional customer service, LGI Homes was named to Newsweek's list of the World's Most Trustworthy Companies. LGI Homes' commitment to excellence extends to its more than 1,000 employees, earning the Company numerous workplace awards at the local, state and national level, including the Top Workplaces USA 2024 Award. For more information about LGI Homes and its unique operating model focused on making the dream of homeownership a reality for families across the nation, please visit the Company's website at MEDIA CONTACT Rachel Eaton (281) 362-8998 ext. 2560 Photos accompanying this announcement are available at Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same.
Business Upturn
5 hours ago
- Business Upturn
Navitas Announces Plans for 200mm GaN Production with PSMC
Next-phase strategy expected to strengthen supply chain, drive innovation, and improve cost efficiency—supporting GaN's ramp into AI data centers, EVs, solar, and home appliances. TORRANCE, Calif., July 01, 2025 (GLOBE NEWSWIRE) — Navitas Semiconductor (Nasdaq: NVTS), the industry leader in next-generation GaNFast™ gallium nitride (GaN) and GeneSiC™ silicon carbide (SiC) power semiconductors, today announced a strategic partnership with Powerchip Semiconductor Manufacturing Corporation (PSMC or Powerchip), to start production and continue development of best-in-class 200mm GaN-on-silicon technology. Navitas' GaN IC portfolio is expected to use Powerchip's 200mm in Fab 8B, located in Zhunan Science Park, Taiwan. The fab has been operational since 2019 and supports various high-volume manufacturing processes for GaN, ranging from micro-LEDs to RF GaN devices. Powerchip's capabilities include an improved 180nm CMOS process, offering smaller and more advanced geometries, which bring improvements in performance, power efficiency, integration, and cost. '200mm GaN-on-silicon production on a 180nm process node enables us to continue innovating higher power density, faster, and more efficient devices while simultaneously improving cost, scale, and manufacturing yields', said Dr. Sid Sundaresan, SVP of WBG Technology Platforms at Navitas. Powerchip is expected to manufacture Navitas' GaN portfolio with voltage ratings from 100V to 650V, supporting the growing demand for GaN for 48V infrastructure, including hyper-scale AI data centers and EVs. Qualification of initial devices is expected in Q4 2025. The 100V family is expected to start production first at Powerchip in 1H26, while the company expects 650V devices will transition from Navitas' existing supplier, TSMC, to Powerchip over the next 12-24 months. Navitas recently made several announcements in the AI data center, EV, and solar markets, including its collaboration with NVIDIA to support GaN and SiC technologies for 800V HVDC architectures for 1 MW IT racks and beyond. Enphase announced that its next-generation IQ9 would include Navitas' 650 V bi-directional GaNFast ICs, and Changan Automobile announced its first commercial GaN-based OBC (on-board charger) using Navitas' GaNSafe technology. 'We are proud to partner with Powerchip to advance high-volume 200 mm GaN-on-silicon production and look forward to driving continued innovation together in the years ahead', said Gene Sheridan, CEO and co-founder of Navitas. 'Through our partnership with Powerchip, we are well-positioned to drive sustained progress in product performance, technological evolution, and cost efficiency.' 'Powerchip has collaborated with Navitas on GaN-on-Si technology for years, and we're thrilled to announce that product qualification is nearly complete – bringing us to the verge of mass production', said Martin Chu, President at Powerchip. 'Building on this strong partnership, Powerchip is committed to expanding our cooperation and continuously supporting Navitas in exploring and growing the GaN market.' About Powerchip Semiconductor Manufacturing Corporation Powerchip Semiconductor Manufacturing Corporation (PSMC) is a Taiwanese semiconductor foundry that develops, manufactures, and distributes advanced memory components and other integrated circuits. Founded in 1994, PSMC operates multiple 12-inch and 8-inch wafer fabs, offering foundry services, design, manufacturing, and testing services. They are recognized for their expertise in developing and manufacturing a range of semiconductor products, including power integrated circuits, discrete components, and image sensors. About Navitas Navitas Semiconductor (Nasdaq: NVTS) is the only pure-play, next-generation power-semiconductor company, celebrating 10 years of power innovation, founded in 2014. GaNFast™ power ICs integrate gallium nitride (GaN) power and drive, with control, sensing, and protection to enable faster charging, higher power density, and greater energy savings. Complementary GeneSiC™ power devices are optimized high-power, high-voltage, and high-reliability silicon carbide (SiC) solutions. Focus markets include AI data centers, EV, solar, energy storage, home appliance / industrial, mobile, and consumer. Over 300 Navitas patents are issued or pending, with the industry's first and only 20-year GaNFast warranty. Navitas was the world's first semiconductor company to be CarbonNeutral®-certified. Navitas Semiconductor, GaNFast, GaNSense, GeneSiC, and the Navitas logo are trademarks or registered trademarks of Navitas Semiconductor Limited and affiliates. All other brands, product names, and marks are or may be trademarks or registered trademarks used to identify products or services of their respective owners. Forward-Looking Statements Statements and information in this press release that are not historical are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and are made pursuant to the 'safe harbor' provisions of such Act. Forward-looking statements may be identified by the use of words such as 'we expect' or 'are expected to be,' 'estimate,' 'plan,' 'project,' 'forecast,' 'intend,' 'anticipate,' 'believe,' 'seek,' or other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. Forward-looking statements are provided for illustrative purposes only and are not intended to serve as, and must not be relied on by any investor as, a guarantee, an assurance, a prediction or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions and expectations. The risks, uncertainties, assumptions and other factors that could cause actual events or results to differ from the events or results predicted or implied by our forward-looking statement include those risk factors discussed in our filings with the SEC, including those disclosed under the caption 'Risk Factors' in our annual report on Form 10-K for the year ended December 31, 2024, our quarterly report on Form 10-Q for the quarter ended March 31, 2025 and subsequent quarterly reports. Navitas may elect to update these forward-looking statements at some point in the future, but specifically disclaims any obligation to do so. Contact InformationLlew Vaughan-Edmunds, Sr Director, Product Management & Marketing [email protected]
Business Wire
6 hours ago
- Business Wire
Fasikl Receives FDA Clearance for Felix NeuroAI Wristband, the First and Only AI-Powered Treatment for Essential Tremor
MINNEAPOLIS--(BUSINESS WIRE)-- Fasikl, a trailblazing neuro-AI company redefining the intersection of advanced bioelectronic medicine and artificial intelligence (AI), today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the first-of-its-kind Felix™ NeuroAI™ Wristband for tremor-related functional limitations in the upper limbs in adults with essential tremor. 'The Felix wristband represents a significant step forward in noninvasive, personalized treatment options for essential tremor,' said Rajesh Pahwa, M.D., Laverne and Joyce Rider Professor of Neurology at the University of Kansas School of Medicine, Director of the Movement Disorder Program at The University of Kansas Health System. 'For many patients, current treatment options fall short — pharmaceutical treatments are helpful for less than 50% of the patients, and deep brain stimulation and focused ultrasound, while effective, require surgical intervention. This new AI wearable wristband backed by clinical evidence is an effective treatment option in patients with essential tremor.' Essential tremor is the most common type of tremor disorder, affecting approximately 7 million people in the U.S., and is about seven times more common than Parkinson's disease. 1,2 It causes involuntary, rhythmic shaking, most often in the hands, which can make simple and everyday activities like drinking from a glass or tying shoelaces difficult. 3 Traditional treatment options are limited, with oral medications providing inconsistent relief and often accompanied by undesirable side effects. 4 Surgical interventions such as deep brain stimulation (DBS), while effective, require invasive procedures, carry surgical risks, and may not be suitable or desirable for all patients, particularly older adults or those with coexisting health conditions. 4 Unlike surgical or pharmacologic interventions, Felix is a noninvasive, wearable device that effortlessly connects to Fasikl's cloud-based AI platform, enabling continuous brain-AI co-adaptation and personalized therapy. Worn on the wrist, it uses the cloud to dynamically adjust stimulation, offering all-day symptom relief while seamlessly fitting into the wearer's lifestyle. The FDA clearance of Felix is supported by compelling data from the TRANQUIL study, a randomized, double-blind, sham-controlled trial that met its primary endpoint. Results showed that the Felix wristband significantly reduced tremors and displayed statistically and clinically significant improvement in the users' ability to perform daily activities compared to those using the sham device ('placebo effect'). Efficacy was consistent across demographics, with no serious device-related adverse events reported. Results were presented as Late-breaking Science at the American Academy of Neurology annual meeting in April 2025, reinforcing Felix's safety and potential as a first-of-its-kind, noninvasive, AI-powered treatment. 'FDA clearance of Felix marks a defining moment for Fasikl and the millions of people living with essential tremor who have long been underserved by existing therapies,' said Zhi Yang, Ph.D., CEO of Fasikl. 'This breakthrough in noninvasive, intelligent, and personalized neuromodulation marks the emergence of AI therapeutics in disease treatment. It offers a new option that is potentially more effective, safer, and more scalable. Our next step is to execute the commercialization plan to support Felix's initial product launch." The Felix NeuroAI Wristband will be available by prescription through healthcare providers in select U.S. regions starting in 2025, with nationwide availability expected in 2026. About Fasikl Based in Minneapolis, Fasikl, Inc. is a pioneering neuro-AI company dedicated to developing advanced, AI-powered neural technologies. A 2019 spin-off from the University of Minnesota, Fasikl leverages its proprietary platform to capture neural signals directly from peripheral nerves, enabling intelligent, adaptive therapy. The company is on a mission to transform the treatment landscape for movement disorders, paralysis, and other neurological impairments through cutting-edge neuromodulation innovations. Fasikl's portfolio includes the FDA-cleared Felix™ NeuroAI™ Wristband and the investigational Fasikl-X™ Nerve-Computer Interface. To learn more, visit References:
